Krystal Biotech to share KB407 cystic fibrosis trial data
Tweet Send to a Friend
Krystal Biotech Inc. (NASDAQ: KRYS) will host an investor conference call on January 8, 2026, at 4:30 p.m. ET to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


